What Should You Know About TFF Pharmaceuticals (TFFP)?

TFF Pharmaceuticals shares fell by -1.35% during the day's afternoon session, and are now trading at a price of $0.72. Is it time to buy the dip? To better answer that question, it's essential to check if the market is valuing the company's shares fairly in terms of its earnings and equity levels.

TFF Pharmaceuticals, Inc., an early-stage biopharmaceutical company, focuses on developing and marketing pharmaceutical products based on its proprietary Thin Film Freezing, or TFF, technology platform in the United States and Australia. The company belongs to the Health Care sector, which has an average price to earnings (P/E) ratio of 24.45 and an average price to book (P/B) ratio of 4.16. In contrast, TFF Pharmaceuticals has a trailing 12 month P/E ratio of -0.61 and a P/B ratio of 1.515.

TFF Pharmaceuticals has moved -88.48% over the last year compared to -7.46% for the S&P 500 — a difference of -81.02%. TFF Pharmaceuticals has a 52 week high of $7.7 and a 52 week low of $0.62.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.